James N. Topper
Director, La Jolla Pharmaceutical Company.
Companies
- Attovia Therapeutics, Inc.Board member Aug 4, 2026 to now1
- NewAmsterdam Pharma Co N.V.Board member Dec 29, 2023 to now2
- Phathom Pharmaceuticals, Inc.Board member Oct 24, 2019 to now3
- Alpine Immune SciencesBoard member Jul 26, 2017 to May 20, 20244
- ANAPTYSBIO, INCBoard member Jan 25, 2017 to Jan 10, 20235
- Frazier Lifesciences Acquisition CorpBoard member Dec 8, 2020 to Dec 17, 20206
- Frazier Lifesciences Acquisition CorpChief executive officer Dec 8, 2020 to Dec 17, 20206
- Allena Pharmaceuticals, Inc.Board member Nov 1, 2017 to Nov 18, 20207
- Aptinyx Inc.Board member Jun 20, 2018 to Apr 2, 20208
- Entasis TherapeuticsBoard member Sep 25, 2018 to Jan 22, 20199
- Sierra Oncology, Inc.Board member Jul 15, 2015 to Feb 16, 201710
- Amicus TherapeuticsBoard member May 30, 2007 to Jun 16, 201411
- La Jolla Pharmaceutical CompanyBoard member Feb 14, 2006 to Feb 26, 200912
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NewAmsterdam Pharma Co N.V. NAMS3,801,000 shares13$77.1M at $20.29Sep 17, 2025
- Phathom Pharmaceuticals, Inc. PHAT70,630 shares14$496.2K at $7.03May 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 19, 2026Granted 24,122 shares of Phathom Pharmaceuticals, Inc.14
- Sep 17, 2025U 17,199 shares at $1.95 of HilleVax, Inc.15
- Sep 17, 2025U 8,535,337 shares at $1.95 of HilleVax, Inc.15
- Sep 15, 2025Bought 660 shares at $23.70 of NewAmsterdam Pharma Co N.V.13
- Sep 8, 2025Bought 1,260 shares at $24.99 of NewAmsterdam Pharma Co N.V.16
- Aug 11, 2025Bought 471 shares at $23.98 of NewAmsterdam Pharma Co N.V.17
- Jun 25, 2025Bought 1,260 shares at $18.26 of NewAmsterdam Pharma Co N.V.18
- Jun 24, 2025Bought 2,520 shares at $18.43 of NewAmsterdam Pharma Co N.V.18
- Jun 16, 2025Bought 8,584 shares at $19.50 of NewAmsterdam Pharma Co N.V.19
- Jun 3, 2025Granted 10,500 shares of Phathom Pharmaceuticals, Inc.20
- May 21, 2025Bought 3,780 shares at $3.86 of Phathom Pharmaceuticals, Inc.21
- May 14, 2025Bought 6,300 shares at $3.32 of Phathom Pharmaceuticals, Inc.22
- May 13, 2025Bought 1,120 shares at $3.16 of Phathom Pharmaceuticals, Inc.22
- May 12, 2025Bought 12,601 shares at $3.04 of Phathom Pharmaceuticals, Inc.23
- May 9, 2025Bought 2,226 shares at $3.62 of Phathom Pharmaceuticals, Inc.23
- May 9, 2025Bought 33,376 shares at $3.19 of Phathom Pharmaceuticals, Inc.23
- Mar 26, 2025Bought 1,135 shares at $22.49 of NewAmsterdam Pharma Co N.V.24
- Mar 4, 2025Bought 4,005 shares at $21.02 of NewAmsterdam Pharma Co N.V.25
- May 23, 2024Granted 10,500 shares of Phathom Pharmaceuticals, Inc.26
- May 18, 2024U 2,829,347 shares of CIK 162619927
- Apr 25, 2024Sold 19 shares at $64.57 of CIK 162619928
- Apr 25, 2024Exercised 1,200,000 shares of CIK 162619928
- Mar 26, 2024Bought 8,429 shares at $21.50 of NewAmsterdam Pharma Co N.V.29
- Dec 11, 2023Exercised 145,251 shares at $12.74 of CIK 162619930
- May 25, 2023Granted 9,000 shares of Phathom Pharmaceuticals, Inc.31
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAlpine Immune Sciences, Board member
- 5SEC EDGARANAPTYSBIO, INC, Board member
- 6
- 7
- 8SEC EDGARAptinyx Inc., Board member
- 9SEC EDGAREntasis Therapeutics, Board member
- 10SEC EDGARSierra Oncology, Inc., Board member
- 11SEC EDGARAmicus Therapeutics, Board member
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Sep 17, 2025
- 16SEC EDGARForm 4 filed Sep 10, 2025
- 17SEC EDGARForm 4 filed Aug 13, 2025
- 18SEC EDGARForm 4 filed Jun 26, 2025
- 19SEC EDGARForm 4 filed Jun 18, 2025
- 20SEC EDGARForm 4 filed Jun 5, 2025
- 21SEC EDGARForm 4 filed May 23, 2025
- 22SEC EDGARForm 4 filed May 15, 2025
- 23SEC EDGARForm 4 filed May 13, 2025
- 24SEC EDGARForm 4 filed Mar 28, 2025
- 25SEC EDGARForm 4 filed Mar 6, 2025
- 26SEC EDGARForm 4 filed May 24, 2024
- 27SEC EDGARForm 4 filed May 20, 2024
- 28SEC EDGARForm 4 filed Apr 29, 2024
- 29SEC EDGARForm 4 filed Mar 28, 2024
- 30SEC EDGARForm 4 filed Dec 13, 2023
- 31SEC EDGARForm 4 filed May 30, 2023